Aldeyra Therapeutics Submits FDA IND Filing for Noninfectious Anterior Uveitis
December 18, 2014 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Dec. 18, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Abstract Accepted at 2015 American Academy of Allergy Asthma & Immunology Annual Meeting
December 16, 2014 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Dec. 16, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Announces Collaboration With the National Organization for Rare Disorders to Enhance Awareness for Sjogren-Larsson Syndrome Patients
December 04, 2014 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Dec. 4, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Present at the Therapeutic Area Partnerships Meeting
November 13, 2014 08:30 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Nov. 13, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Reports Third Quarter and Year to Date 2014 Financial Results
November 10, 2014 08:16 ET
|
Aldeyra Therapeutics
LEXINGTON, Mass., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results
November 03, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
Aldeyra Therapeutics to Present at Upcoming Investor Conferences
September 05, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., Sept. 5, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Expands Drug Development Team in Advance of NS2 Clinical Trials
September 02, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., Sept. 2, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
Aldeyra Therapeutics Reports Second Quarter 2014 Financial Results
August 04, 2014 07:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., Aug. 4, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases thought to be...
Aldeyra Therapeutics Schedules Webcast and Conference Call for Second Quarter 2014 Financial Results
July 23, 2014 08:30 ET
|
Aldeyra Therapeutics
BURLINGTON, Mass., July 23, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases thought to be...